123 related articles for article (PubMed ID: 15931383)
1. Stem cell-ness: a "magic marker" for cancer.
Lahad JP; Mills GB; Coombes KR
J Clin Invest; 2005 Jun; 115(6):1463-7. PubMed ID: 15931383
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.
Glinsky GV; Berezovska O; Glinskii AB
J Clin Invest; 2005 Jun; 115(6):1503-21. PubMed ID: 15931389
[TBL] [Abstract][Full Text] [Related]
3. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
4. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
[TBL] [Abstract][Full Text] [Related]
5. [Molecular profiling and predictive signatures. Biomarker analysis in ovarian cancer].
Denkert C
Pathologe; 2008 Nov; 29 Suppl 2():168-71. PubMed ID: 18931999
[TBL] [Abstract][Full Text] [Related]
6. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
[TBL] [Abstract][Full Text] [Related]
7. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
[TBL] [Abstract][Full Text] [Related]
8. Activation of endogenous human stem cell-associated retroviruses (SCARs) and therapy-resistant phenotypes of malignant tumors.
Glinsky GV
Cancer Lett; 2016 Jul; 376(2):347-59. PubMed ID: 27084523
[TBL] [Abstract][Full Text] [Related]
9. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.
Grosse-Gehling P; Fargeas CA; Dittfeld C; Garbe Y; Alison MR; Corbeil D; Kunz-Schughart LA
J Pathol; 2013 Feb; 229(3):355-78. PubMed ID: 22899341
[TBL] [Abstract][Full Text] [Related]
10. Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.
Henriquez NV; Forshew T; Tatevossian R; Ellis M; Richard-Loendt A; Rogers H; Jacques TS; Reitboeck PG; Pearce K; Sheer D; Grundy RG; Brandner S
Cancer Res; 2013 Sep; 73(18):5834-44. PubMed ID: 23887970
[TBL] [Abstract][Full Text] [Related]
11. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
12. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.
Miltiadous O; Sia D; Hoshida Y; Fiel MI; Harrington AN; Thung SN; Tan PS; Dong H; Revill K; Chang CY; Roayaie S; Byrne TJ; Mazzaferro V; Rakela J; Florman S; Schwartz M; Llovet JM
J Hepatol; 2015 Dec; 63(6):1368-77. PubMed ID: 26220754
[TBL] [Abstract][Full Text] [Related]
13. Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.
Fiebig HH; Schüler J; Bausch N; Hofmann M; Metz T; Korrat A
Cancer Genomics Proteomics; 2007; 4(3):197-209. PubMed ID: 17878523
[TBL] [Abstract][Full Text] [Related]
14. Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers.
Mousa SA; Sudha T; Dyskin E; Dier U; Gallati C; Hanko C; Chittur SV; Rebbaa A
Cancer Lett; 2010 Mar; 289(2):208-16. PubMed ID: 19733430
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling as a tool for basic analysis and clinical application of human cancer.
García-Escudero R; Paramio JM
Mol Carcinog; 2008 Aug; 47(8):573-9. PubMed ID: 18324660
[TBL] [Abstract][Full Text] [Related]
16. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
17. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
[TBL] [Abstract][Full Text] [Related]
18. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
20. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.
Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M
Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
